We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Adaptive Biotechnologies Aquires Sequenta, Inc.

News   Jan 08, 2015

 
Adaptive Biotechnologies Aquires Sequenta, Inc.
 
 
Advertisement
 

RELATED ARTICLES

Genetic Variation, Chromatin Accessibility and Neuropsychiatric Disorders

News

A new study took a novel approach to identifying SNPs influencing the risk of neuropsychiatric disorders like schizophrenia, bipolar and major depressive disorder.

READ MORE

Two Is Better Than One for Novel COVID-19 Mouse Model

News

Researchers have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

READ MORE

Embryos Could Be Susceptible to Coronavirus, Study Suggests

News

Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and the California Institute of Technology. The researchers say this could mean embryos are susceptible to COVID-19 if the mother gets sick, potentially affecting the chances of a successful pregnancy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE